Cerebral Angiography Market

Cerebral Angiography Market By Technology (Magnetic Resonance Angiography, Computed Tomography, Ultrasound, Nuclear Imaging, X-ray), By End User (Hospitals, Diagnostic Imaging Centers) & Region - Global Market Insights 2022 to 2027

Analysis of Cerebral Angiography market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Cerebral Angiography Market Outlook (2022-2027)

The global cerebral angiography market currently accounts for a valuation of US$ 46 million and is expected to reach US$ 70 million by the end of 2027. Worldwide demand for cerebral angiography is predicted to increase at a robust CAGR of 8.8% from 2022 to 2027.

Demand for cerebral angiography systems is anticipated to rise faster in China than the global average, at 12% CAGR through 2027. In China, the development needed for the entire treatment of cardiovascular disorders in the healthcare industry is aided by solid assistance from government institutions.

Report Attributes

Details

Cerebral Angiography Market Size (2022)

US$ 46 Million

Projected Market Value (2027)

US$ 70 Million

Global Market Growth Rate (2022-2027)

8.8% CAGR

Share in Angiography Market (2022)

0.5%

Market Share of China

22%

Key Companies Profiled

  • GE Healthcare
  • Samsung Medison
  • Shimadzu Corp.
  • Siemens Healthineers
  • TERUMO Corporation
  • St. Jude Medical, Inc.
  • Hitachi Medical Corporation
  • Koninklijke Philips N.V.
  • Toshiba Medical Systems Corporation

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Revenue Analysis of Cerebral Angiography (2017-2021) Vs. Industry Outlook (2022-2027)

“Growing Demand for Interventional Angiography Devices for Use in Minimally-invasive Operations”

According to Fact.MR, a market research and competitive intelligence provider, the cerebral angiography market is projected to increase at a CAGR of 8.8% from 2022 to 2027.

A tubing (a lengthy, thin, adaptable tube) is placed into an artery in the arm or leg during cerebral angiography. A technician injects a particular dye into the blood arteries using the tubing, which causes a chemical reaction in the brain. It is a method of delivering x-ray images of the interiors of blood vessels.

The market for cerebral angiography is primarily driven by an increase in cardiovascular disease patients as well as an increase in awareness campaigns, conferences, and funding initiatives. Additionally, the market for cerebral angiography is growing due to the rise in demand for interventional angiography devices in minimally-invasive operations.

Carotid Doppler results are less reliable than those from cerebral angiography. The use of cerebral angiography typically follows the discovery of an abnormality by another test. Acute stroke detection and diagnosis are assisted by angiography. Other methods cannot produce the images that come from cerebral angiography.

Cerebral angiography market forecast by Fact.MR

What Opportunities Lie Ahead for Key Providers of Cerebral Angiography Devices?

“Innovation in Cerebral Angiography Techniques for Better Diagnosis and Treatment”

Cardiovascular disease treatment with 3D printing is becoming more popular, and it may also be used to prevent disease in the future. Using heart valves that are 3D manufactured from living tissue, aortic valve failure can be addressed without the use of prosthetic valves. The market for cerebral angiography is being driven by healthcare industry innovation and investments.

There are many potential causes of brain aneurysms, including smoking, high blood pressure, and family history. The most frequent causes of a brain aneurysm are an irregular degenerative change in the arterial wall and the pressure created by blood flow pulsations through the brain's arteries. All across the world, brain aneurysms are becoming far more common. The increasing prevalence of cerebral aneurysms is driving market expansion.

A minimally-invasive medical technique involves making a small incision or opening in the body and putting a small device or implant into the body. The acceptance of minimally-invasive surgery equipment has grown significantly in recent years. Because of the little incisions, the patient recovers more quickly and with less pain. Less stress to the muscles, nerves, and tissues, few minor cuts, less bleeding and scarring, restricted pain, quicker oral intake, and shorter hospital stays are all advantages of minimally-invasive procedures.

Over time, there has been a sharp increase in cardiovascular disorders. The growth of the cerebral angiography market is strongly correlated with the rising prevalence of cardiovascular diseases and disorders. Especially in low- and middle-income countries, cardiovascular illnesses are among the most common causes of death worldwide. The market for cerebral angiography is expected to develop tremendously as a result of these causes.

Innovation in cerebral angiography techniques for better diagnosis and treatment has significantly improved the angiography processes. The market for cerebral angiography has a lot of room to develop due to the simplicity and benefits of these technologies.

Market participants are conducting a variety of awareness efforts to enlighten people about the most recent angiography technologies. These programs also aid in educating the general public about angiography-related technology and its advantages. These awareness campaigns are boosting the sales of cerebral angiography products.

What Could Downgrade Demand for Cerebral Angiography Systems?

“Lack of Skilled Professionals & Poor Reimbursement Policies”

The reasons limiting market growth include a lack of skilled professionals, an increase in product recalls, the existence of strict laws related to medical device safety, and poor reimbursement policies.

Furthermore, a barrier to further adoption of cerebral angiography machines is growing product advancements with fresh and inventive qualities that raise the price of equipment. The high cost of the associated devices raises the cost of the treatment, forcing patients to pay exorbitant prices, demonstrating unaffordability.

What are Emerging Market Players Focusing On?

“New Market Players Making Significant Investments in Development of New Technologies that Enhance Patient Outcomes”

Industry start-ups are emphasizing the development of cutting-edge products that are more precise and efficient. New companies are making significant investments in advancements of new technologies, which is anticipated to boost market expansion.

New entrants are concentrating on the introduction of novel cerebral angiography devices, expansion plans, and technological improvements. These advancements are expected to accelerate market growth over the coming years.

  • Caristo is an Oxford-based start-up that offers tools for identifying cardiovascular risks. It provides invasive, individualized cardiovascular issue screening using its patented technologies. For modelling cardiac CT scans to detect fat tissue surrounding the coronary arteries known as the Fat Attenuation Index, it uses its patented method of Cardiac Computed Tomography Angiography (CCTA).

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Which Region is Expected to Lead Global Market Expansion Going Forward?

“Rapidly Growing Utilization of Cerebral Computed Tomography Techniques in North America”

North America leads the cerebral angiography market. This is because appropriate reimbursement policies support advanced features of cerebral angiography devices.

Growing utilization of cerebral computed tomography techniques, expanding need for effective medical device technologies, rising adoption rates of contemporary & revolutionary medical imaging techniques, and rising prevalence of coronary heart disease are anticipated to drive market expansion in North America.

Country-wise Insights

How is the Market for Cerebral Angiography Evolving in the U.S.?

“Rapid Product Approval Processes and Increasing Angiography Device Usage in the U.S.”

The market in the U.S. is expanding due to the widespread use of minimally-invasive treatments, the availability of reimbursements, rising adoption of cerebral thrombectomy devices, the growing elderly population, a strong network of medical device manufacturers, and the rising number of hospitals with lucrative funding prospects.

The U.S. market is expanding due to rapid product approval processes and increasing angiography device usage as a result of the high volume of angiography screening procedures being conducted.

What Makes China a Lucrative Market for Cerebral Angiography?

“Government Intervention for Betterment of Healthcare Sector Driving Market Value in China”

China accounts for 22% share of the global cerebral angiography market.

Rising prevalence of neurological illnesses, government intervention for the betterment of the healthcare sector, and rising healthcare expenditure are contributing to market expansion in China.

Drivers propelling market expansion in China are continuous improvements in healthcare facilities, growth in the R&D sector, rapid innovations in cerebral angiography equipment, rise in healthcare reforms, and technological developments in stroke management.

Category-wise Insights

Which Technology is Gaining Huge Popularity in This Space?

“Growing Usage of Magnetic Resonance Angiography for Rapid Diagnosis of Heart Diseases”

Based on technology, the cerebral angiography market is divided into, magnetic resonance angiography, computed tomography, ultrasound, nuclear imaging, and X-ray. Magnetic resonance angiography accounts for the highest share of the global market.

Magnetic resonance angiography is one of the most widely utilized diagnostic imaging methods on a global scale. It is frequently seen as essential for identifying, managing, and treating a variety of serious disorders.

The creation of this system is seen as a significant advancement in medical imaging due to the non-invasive, potentially safe, and detailed images of anomalies produced by the human body. As the number of cancer and trauma cases increases globally, so does the utilization of imaging equipment for diagnosis.

Due to its low radiation exposure, MRA is predicted to be the technique that diagnoses heart illness at the fastest rate. Any anatomical plane can be imaged using MRA, and 3D soft tissue contrast is excellent. The detection of coronary artery disease has significantly improved with the development of 3.0T MR imaging. These elements are driving the demand for magnetic resonance angiography.

Which End User is Likely to Contribute the Most to Market Expansion?

“Wide Accessibility of Skilled Medical Personnel in Hospitals”

The cerebral angiography market is segmented into hospitals, diagnostic imaging centers, and others based end user.

The wide range of patients who are diagnosed and treated in hospitals, high resource availability, the high purchasing power of hospitals for cutting-edge technologies, and the availability of supporting healthcare infrastructure and procedures are the main factors contributing to the dominance of the hospital segment.

Accessibility of skilled labor, affordability through government funding, and the growing awareness of the effects of early disease diagnosis can all be attributed to segment growth.

When compared to specialty clinics, hospitals are more accessible and more affordable, which draws a huge patient base of people with cardiovascular illnesses. As a result of trade agreements with manufacturers and suppliers and discounts for large purchases, hospitals' profitability indices also rise.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Competitive Landscape

Companies in the cerebral angiography market are investing in R&D to diversify their product offerings. Partnerships between major industry players are anticipated to fuel market expansion over the coming years.

For instance :

  • In 2021, Royal Philips announced its interventional medicine vision by integrating its ground-breaking spectral CT imaging technology into a hybrid Angio CT suite. Through the integration of its distinctive Spectral CT 7500 system and its image-guided therapy system - Azurion with FlexArm into a single interventional suite solution, Philips wants to provide interventionalists with instant table-side access to these two important imaging modalities.

Segmentation of Cerebral Angiography Industry Research

  • By Technology :

    • Magnetic Resonance Angiography
    • Computed Tomography
    • Ultrasound
    • Nuclear Imaging
    • X-ray
  • By End User :

    • Hospitals
    • Diagnostic Imaging Centers
    • Others
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions/Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Technology modifications /Innovation

4. Key Success Factors

    4.1. Strategic Developments

    4.2. Key regulations

    4.3. Technology USPs /Technology

    4.4. List of Manufacturers and Providers

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP outlook

        5.1.2. Increasing R&D Expenditure

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. New Technology launches

        5.2.2. Cost of Technologys

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as Compared to 2008 Economic analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Technology

        6.4.2. Revenue By End Use

        6.4.3. Revenue By Country

    6.5. 2021 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected Recovery Quarter

7. Global Cerebral Angiography Market Volume (Units) Analysis 2017-2021 and Forecast, 2022-2027

    7.1. Historical Market Volume (Units) Analysis, 2017-2021

    7.2. Current and Future Market Volume (Units) Projections, 2022-2027

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Cerebral Angiography Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Technology

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global Cerebral Angiography Market Value Analysis 2017–2021 and Forecast, 2022-2027

    9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2027

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027, by Technology

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Technologys & Services, 2017–2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2027

        10.3.1. Magnetic Resonance Angiography

        10.3.2. Computed Tomography

        10.3.3. Ultrasound

        10.3.4. Nuclear Imaging

        10.3.5. X-ray

    10.4. Market Attractiveness Analysis By Technology

11. Global Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027, by End Use

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By End Use , 2017–2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End Use , 2022-2027

        11.3.1. Hospitals

        11.3.2. Diagnostic Imaging Centers

        11.3.3. Others

    11.4. Market Attractiveness Analysis By End Use

12. Global Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021

    12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2027

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Technology

        13.3.3. By End Use

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Technology

        14.3.3. By End Use

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. Russia

            15.3.1.7. Rest of Europe

        15.3.2. By Technology

        15.3.3. By End Use

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Technology

        16.3.3. By End Use

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. East Asia Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

            17.3.1.4. Rest of East Asia

        17.3.2. By Technology

        17.3.3. By End Use

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Oceania Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Technology

        18.3.3. By End Use

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. South Africa

            19.3.1.3. Rest of Middle East and Africa

        19.3.2. By Technology

        19.3.3. By End Use

    19.4. Market Attractiveness Analysis

    19.5. Drivers and Restraints - Impact Analysis

20. Key and Emerging Countries Cerebral Angiography Market Analysis 2017–2021 and Forecast 2022-2027

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Cerebral Angiography Market Analysis

        20.2.1. By Technology

        20.2.2. By End Use

    20.3. Canada Cerebral Angiography Market Analysis

        20.3.1. By Technology

        20.3.2. By End Use

    20.4. Mexico Cerebral Angiography Market Analysis

        20.4.1. By Technology

        20.4.2. By End Use

    20.5. Brazil Cerebral Angiography Market Analysis

        20.5.1. By Technology

        20.5.2. By End Use

    20.6. U.K. Cerebral Angiography Market Analysis

        20.6.1. By Technology

        20.6.2. By End Use

    20.7. Germany Cerebral Angiography Market Analysis

        20.7.1. By Technology

        20.7.2. By End Use

    20.8. France Cerebral Angiography Market Analysis

        20.8.1. By Technology

        20.8.2. By End Use

    20.9. Italy Cerebral Angiography Market Analysis

        20.9.1. By Technology

        20.9.2. By End Use

    20.10. Spain Cerebral Angiography Market Analysis

        20.10.1. By Technology

        20.10.2. By End Use

    20.11. BENELUX Cerebral Angiography Market Analysis

        20.11.1. By Technology

        20.11.2. By End Use

    20.12. Russia Cerebral Angiography Market Analysis

        20.12.1. By Technology

        20.12.2. By End Use

    20.13. China Cerebral Angiography Market Analysis

        20.13.1. By Technology

        20.13.2. By End Use

    20.14. Japan Cerebral Angiography Market Analysis

        20.14.1. By Technology

        20.14.2. By End Use

    20.15. South Korea Cerebral Angiography Market Analysis

        20.15.1. By Technology

        20.15.2. By End Use

    20.16. India Cerebral Angiography Market Analysis

        20.16.1. By Technology

        20.16.2. By End Use

    20.17. ASEAN Cerebral Angiography Market Analysis

        20.17.1. By Technology

        20.17.2. By End Use

    20.18. Australia Cerebral Angiography Market Analysis

        20.18.1. By Technology

        20.18.2. By End Use

    20.19. New Zealand Cerebral Angiography Market Analysis

        20.19.1. By Technology

        20.19.2. By End Use

    20.20. GCC Countries Cerebral Angiography Market Analysis

        20.20.1. By Technology

        20.20.2. By End Use

    20.21. Turkey Cerebral Angiography Market Analysis

        20.21.1. By Technology

        20.21.2. By End Use

    20.22. South Africa Cerebral Angiography Market Analysis

        20.22.1. By Technology

        20.22.2. By End Use

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. By Regional footprint of Players

        21.4.2. Technology foot print by Players

        21.4.3. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep dive

        22.3.1. GE Healthcare

            22.3.1.1. Overview

            22.3.1.2. Technology Portfolio

            22.3.1.3. Profitability by Market Segments (Technology/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.2. Samsung Medison

            22.3.2.1. Overview

            22.3.2.2. Technology Portfolio

            22.3.2.3. Profitability by Market Segments (Technology/Channel/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

        22.3.3. Shimadzu Corp.

            22.3.3.1. Overview

            22.3.3.2. Technology Portfolio

            22.3.3.3. Profitability by Market Segments (Technology/Channel/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

        22.3.4. Siemens Healthineers

            22.3.4.1. Overview

            22.3.4.2. Technology Portfolio

            22.3.4.3. Profitability by Market Segments (Technology/Channel/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

        22.3.5. TERUMO Corporation

            22.3.5.1. Overview

            22.3.5.2. Technology Portfolio

            22.3.5.3. Profitability by Market Segments (Technology/Channel/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

        22.3.6. St. Jude Medical, Inc.

            22.3.6.1. Overview

            22.3.6.2. Technology Portfolio

            22.3.6.3. Profitability by Market Segments (Technology/Channel/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

        22.3.7. Hitachi Medical Corporation

            22.3.7.1. Overview

            22.3.7.2. Technology Portfolio

            22.3.7.3. Profitability by Market Segments (Technology/Channel/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

        22.3.8. Koninklijke Philips N.V.

            22.3.8.1. Overview

            22.3.8.2. Technology Portfolio

            22.3.8.3. Profitability by Market Segments (Technology/Channel/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

        22.3.9. Toshiba Medical Systems Corporation

            22.3.9.1. Overview

            22.3.9.2. Technology Portfolio

            22.3.9.3. Profitability by Market Segments (Technology/Channel/Region)

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Cerebral Angiography Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017–2027, By Technology

Table 02: Global Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Technology

Table 03: Global Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End Use

Table 04: Global Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Region

Table 05: North America Cerebral Angiography Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 06: North America Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Technology

Table 07: North America Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End Use

Table 08: Latin America Cerebral Angiography Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 09: Latin America Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Technology

Table 10: Latin America Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End Use

Table 11: Europe Cerebral Angiography Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 12: Europe Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Technology

Table 13: Europe Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End Use

Table 14: South Asia Cerebral Angiography Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 15: South Asia Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Technology

Table 16: South Asia Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End Use

Table 17: East Asia Cerebral Angiography Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 18: East Asia Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Technology

Table 19: East Asia Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End Use

Table 20: Oceania Cerebral Angiography Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 21: Oceania Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Technology

Table 22: Oceania Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End Use

Table 23: Middle East and Africa Cerebral Angiography Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 24: Middle East and Africa Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Technology

Table 25: Middle East and Africa Cerebral Angiography Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End Use

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Cerebral Angiography Market Volume (in 000' Units) Analysis, 2017-2021

Figure 02: Global Cerebral Angiography Market Volume Forecast (in 000' Units), 2022-2027

Figure 03: Cerebral Angiography Pricing Analysis (US$) Per Technology, By Region, 2021

Figure 04: Cerebral Angiography Pricing Analysis (US$) Per Technology, By Region, 2021

Figure 05: Global Cerebral Angiography Market Value Analysis (US$ Mn), 2017-2021

Figure 06: Global Cerebral Angiography Market Value Forecast (US$ Mn), 2022-2027

Figure 07: Global Cerebral Angiography Market Absolute $ Opportunity, 2022-2027

Figure 08: Global Cerebral Angiography Market Share Analysis (%), By Technology, 2022-2027

Figure 09: Global Cerebral Angiography Market Y-o-Y Analysis (%), By Technology, 2022-2027

Figure 10: Global Cerebral Angiography Market Attractiveness Analysis by Technology, 2022-2027

Figure 11: Global Cerebral Angiography Market Share Analysis (%), By End Use, 2022-2027

Figure 12: Global Cerebral Angiography Market Y-o-Y Analysis (%), By End Use, 2022-2027

Figure 13: Global Cerebral Angiography Market Attractiveness Analysis by End Use, 2022-2027

Figure 14: Global Cerebral Angiography Market Share Analysis (%), By Region, 2022-2027

Figure 15: Global Cerebral Angiography Market Y-o-Y Analysis (%), By Region, 2022-2027

Figure 16: Global Cerebral Angiography Market Attractiveness Analysis by Region, 2022-2027

Figure 17: North America Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 18: North America Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 19: North America Cerebral Angiography Market Value Share, By Country, 2022 (E)

Figure 20: North America Cerebral Angiography Market Value Analysis (US$ Mn), 2017-2021

Figure 21: North America Cerebral Angiography Market Value Forecast (US$ Mn), 2022-2027

Figure 22: North America Cerebral Angiography Market Attractiveness Analysis by Technology, 2022-2027

Figure 23: North America Cerebral Angiography Market Attractiveness Analysis by End Use, 2022-2027

Figure 24: North America Cerebral Angiography Market Attractiveness Analysis by Country, 2022-2027

Figure 25: Latin America Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 26: Latin America Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 27: Latin America Cerebral Angiography Market Value Share, By Country, 2022 (E)

Figure 28: Latin America Cerebral Angiography Market Value Analysis (US$ Mn), 2017-2021

Figure 29: Latin America Cerebral Angiography Market Value Forecast (US$ Mn), 2022-2027

Figure 30: Latin America Cerebral Angiography Market Attractiveness Analysis by Technology, 2022-2027

Figure 31: Latin America Cerebral Angiography Market Attractiveness Analysis by End Use, 2022-2027

Figure 32: Latin America Cerebral Angiography Market Attractiveness Analysis by Country, 2022-2027

Figure 33: Europe Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 34: Europe Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 35: Europe Cerebral Angiography Market Value Share, By Country, 2022 (E)

Figure 36: Europe Cerebral Angiography Market Value Analysis (US$ Mn), 2017-2021

Figure 37: Europe Cerebral Angiography Market Value Forecast (US$ Mn), 2022-2027

Figure 38: Europe Cerebral Angiography Market Attractiveness Analysis by Technology, 2022-2027

Figure 39: Europe Cerebral Angiography Market Attractiveness Analysis by End Use, 2022-2027

Figure 40: Europe Cerebral Angiography Market Attractiveness Analysis by Country, 2022-2027

Figure 41: South Asia Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 42: South Asia Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 43: South Asia Cerebral Angiography Market Value Share, By Country, 2022 (E)

Figure 44: South Asia Cerebral Angiography Market Value Analysis (US$ Mn), 2017-2021

Figure 45: South Asia Cerebral Angiography Market Value Forecast (US$ Mn), 2022-2027

Figure 46: South Asia Cerebral Angiography Market Attractiveness Analysis by Technology, 2022-2027

Figure 47: South Asia Cerebral Angiography Market Attractiveness Analysis by End Use, 2022-2027

Figure 48: South Asia Cerebral Angiography Market Attractiveness Analysis by Country, 2022-2027

Figure 49: East Asia Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 50: East Asia Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 51: East Asia Cerebral Angiography Market Value Share, By Country, 2022 (E)

Figure 52: East Asia Cerebral Angiography Market Value Analysis (US$ Mn), 2017-2021

Figure 53: East Asia Cerebral Angiography Market Value Forecast (US$ Mn), 2022-2027

Figure 54: East Asia Cerebral Angiography Market Attractiveness Analysis by Technology, 2022-2027

Figure 55: East Asia Cerebral Angiography Market Attractiveness Analysis by End Use, 2022-2027

Figure 56: East Asia Cerebral Angiography Market Attractiveness Analysis by Country, 2022-2027

Figure 57: Oceania Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 58: Oceania Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 59: Oceania Cerebral Angiography Market Value Share, By Country, 2022 (E)

Figure 60: Oceania Cerebral Angiography Market Value Analysis (US$ Mn), 2017-2021

Figure 61: Oceania Cerebral Angiography Market Value Forecast (US$ Mn), 2022-2027

Figure 62: Oceania Cerebral Angiography Market Attractiveness Analysis by Technology, 2022-2027

Figure 63: Oceania Cerebral Angiography Market Attractiveness Analysis by End Use, 2022-2027

Figure 64: Oceania Cerebral Angiography Market Attractiveness Analysis by Country, 2022-2027

Figure 65: Middle East and Africa Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 66: Middle East and Africa Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 67: Middle East and Africa Cerebral Angiography Market Value Share, By Country, 2022 (E)

Figure 68: Middle East and Africa Cerebral Angiography Market Value Analysis (US$ Mn), 2017-2021

Figure 69: Middle East and Africa Cerebral Angiography Market Value Forecast (US$ Mn), 2022-2027

Figure 70: Middle East and Africa Cerebral Angiography Market Attractiveness Analysis by Technology, 2022-2027

Figure 71: Middle East and Africa Cerebral Angiography Market Attractiveness Analysis by End Use, 2022-2027

Figure 72: Middle East and Africa Cerebral Angiography Market Attractiveness Analysis by Country, 2022-2027

Figure 73: U. S. Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 74: U. S. Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 75: U. S. Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 76: Canada Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 77: Canada Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 78: Canada Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 79: Mexico Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 80: Mexico Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 81: Mexico Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 82: Brazil Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 83: Brazil Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 84: Brazil Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 85: U. K. Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 86: U. K. Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 87: U. K. Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 88: Germany Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 89: Germany Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 90: Germany Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 91: France Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 92: France Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 93: France Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 94: Italy Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 95: Italy Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 96: Italy Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 97: Spain Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 98: Spain Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 99: Spain Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 100: Russia Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 101: Russia Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 102: Russia Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 103: China Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 104: China Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 105: China Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 106: Japan Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 107: Japan Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 108: Japan Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 109: South Korea Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 110: South Korea Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 111: South Korea Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 112: India Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 113: India Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 114: India Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 115: ASEAN Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 116: ASEAN Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 117: ASEAN Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 118: Australia Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 119: Australia Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 120: Australia Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 121: New Zealand Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 122: New Zealand Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 123: New Zealand Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 124: GCC Countries Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 125: GCC Countries Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 126: GCC Countries Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 127: Turkey Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 128: Turkey Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 129: Turkey Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Figure 130: South Africa Cerebral Angiography Market Value Analysis (US$ Mn), 2022 & 2027

Figure 131: South Africa Cerebral Angiography Market Value Share, By Technology, 2022 (E)

Figure 132: South Africa Cerebral Angiography Market Value Share, By End Use, 2022 (E)

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What is the current value of the market for cerebral angiography?

The global cerebral angiography market currently stands at US$ 46 million.

What is the predicted growth rate for the global market for cerebral angiography?

The cerebral angiography market is set to surge ahead at a CAGR of 8.8% from 2022 to 2027.

What is the forecasted size of the global market for cerebral angiography?

Worldwide revenue from cerebral angiography is estimated to reach US$ 70 million by 2027.

Which are the key companies in the cerebral angiography market?

GE Healthcare, Samsung Medison, and Shimadzu Corp. are key manufacturers of cerebral angiography systems.

What is the estimated CAGR for the market in Germany?

The market in Germany is set to rise at 6% CAGR through 2027.

Cerebral Angiography Market

Schedule a Call